Rosebud Biosciences

Rosebud Biosciences is an early-stage startup focused on developing therapies for rare genetic diseases in children. Recognizing the significant unmet need in this area, the company aims to address the fact that 95% of genetic diseases currently lack approved treatments. By harnessing advanced modeling techniques, Rosebud seeks to uncover potential cures for these conditions, which affect millions of individuals worldwide, particularly children who are disproportionately impacted by these diseases.